CClaimWatch
Plaintiff counsel in 3 cases

DONALD A. ECKLUND

CARELLA, BYRNE, CECCHI, OLSTEIN, BRODY & AGNELLO, P.C.

Address of record
5 BECKER FARM ROAD, ROSELAND, NJ 07068, (973) 994-1700
Email
decklund@carellabyrne.com
Phone
(973) 994-1700
Fax
Fax (973) 994-1744

Contact details as filed with the court in the cases below.

5
Cases tracked
0 active · 5 settled
$100M
Plaintiff-side recovery
Disclosed settlement funds
—
Defense-side exposure
Resolved in settlements
2
Cases with values
of 5 tracked

Case history

Publicly tracked matters where this attorney is listed as counsel.

CounselSettled — accepting claims

Eagle Pharma Securities Litigation Settlement

Eagle Pharmaceuticals, Inc. is the subject of a securities litigation class action. Shareholders who purchased the company's publicly traded common stock between August 9, 2022 and October 1, 2024 allege claims covered by this settlement, which the defendant has agreed to settle.

Claim deadline
October 16, 2026
Represents
STEPHEN MARSHALL, EVANS ASSOCIATES I, LLC
Plaintiff counselSettled — claims closed

TAP Air Portugal Flight Cancellation Settlement

TAP Air Portugal allegedly canceled flights between March 1, 2020, and December 31, 2021, without providing full refunds to passengers. TAP has agreed to settle the lawsuit and provide cash payments to eligible customers.

Claim deadline
August 5, 2025
Represents
JON TOWER
CounselSettled — claims closed

Becton, Dickinson and Company Securities Litigation Settlement

Becton, Dickinson and Company and its former CEO Thomas E. Polen allegedly violated federal securities laws by misrepresenting the nature, extent, and revenue impact of undisclosed product issues, compliance violations, and FDA scrutiny regarding BD's Alaris infusion pump system during November 2019 to February 2020. The defendants have denied all wrongdoing while agreeing to settle for $85 million.

Settlement fund
$85M
Claim deadline
June 14, 2024
Represents
INDUSTRIENS PENSIONSFORSIKRING A/S
Plaintiff counselSettled — claims closed

Novo Nordisk Securities Litigation Settlement

Novo Nordisk and three individual executives allegedly violated federal securities laws by making false and misleading statements about the company's business and financial results. The defendants deny all allegations and maintain they have valid defenses. The settlement was approved for $100 million in July 2022.

Settlement fund
$100M
Claim deadline
Represents
LEHIGH COUNTY EMPLOYEES' RETIREMENT SYSTEM
Plaintiff counselSettled — claims closed

Liquid Aluminum Sulfate Antitrust Settlement

Major manufacturers of liquid aluminum sulfate (Alum) allegedly engaged in a price-fixing conspiracy from 1997 through at least February 2011 to artificially inflate the price of this chemical used in municipal water treatment, causing municipalities and their taxpayers to overpay millions of dollars.

Claim deadline
Represents
CITY OF WINTER PARK

“Recovery” and “exposure” refer to total disclosed settlement funds in associated cases, not money personally won or lost by an attorney. Settlements generally resolve disputed allegations without a finding that either side won. Data comes from public court dockets and may be incomplete.